Viking Therapeutics (VKTX) Assets Average (2016 - 2025)
Historic Assets Average for Viking Therapeutics (VKTX) over the last 11 years, with Q3 2025 value amounting to $783.6 million.
- Viking Therapeutics' Assets Average fell 1684.39% to $783.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $783.6 million, marking a year-over-year decrease of 1684.39%. This contributed to the annual value of $638.4 million for FY2024, which is 13775.9% up from last year.
- Per Viking Therapeutics' latest filing, its Assets Average stood at $783.6 million for Q3 2025, which was down 1684.39% from $847.4 million recorded in Q2 2025.
- Viking Therapeutics' 5-year Assets Average high stood at $957.2 million for Q2 2024, and its period low was $159.7 million during Q1 2023.
- In the last 5 years, Viking Therapeutics' Assets Average had a median value of $275.8 million in 2023 and averaged $467.9 million.
- Its Assets Average has fluctuated over the past 5 years, first plummeted by 2468.6% in 2022, then surged by 31825.54% in 2024.
- Viking Therapeutics' Assets Average (Quarter) stood at $217.6 million in 2021, then decreased by 22.96% to $167.6 million in 2022, then skyrocketed by 124.08% to $375.6 million in 2023, then surged by 145.78% to $923.1 million in 2024, then decreased by 15.11% to $783.6 million in 2025.
- Its last three reported values are $783.6 million in Q3 2025, $847.4 million for Q2 2025, and $887.7 million during Q1 2025.